Literature DB >> 8491163

Fatty acid compositions of inositol and choline phospholipids of breast tumours and normal breast tissue.

C M Williams1, K Maunder.   

Abstract

The fatty acid compositions of the -choline and -inositol phospholipids of breast tumours of women undergoing surgery for treatment of breast disease (malignant n = 12; benign n = 10) and normal breast tissue of women undergoing breast reduction surgery (n = 6) were determined. The fatty acid compositions of erythrocyte phospholipids were also determined in the same subjects and in an additional number of normal healthy volunteers (n = 16). Levels of oleic acid were lower in both phospholipid fractions of erythrocytes of women with breast disease and in the phosphatidylcholine fraction of breast tumours compared with normal breast tissue. Significantly higher levels of linoleic acid were found in erythrocytes of tumour-bearing subjects and a similar trend was evident in the phosphatidylcholine fraction of tumour compared with normal breast tissues. Conversely, lower levels of two of the products of linoleic acid chain elongation and desaturation, dihomogamma-linolenic and arachidonic acids, were found in the erythrocyte phospholipids of tumour-bearing subjects and in the choline phospholipids of breast tumour tissues. These data suggest that in women with breast disease, there may be inhibition of 6-desaturase, and enhanced activity of 9-desaturase, enzymes which play an important role in determining membrane phospholipid fatty acid composition. This pattern of altered fatty acid composition characteristic of erythrocyte phospholipids of tumour-bearing subjects and phosphatidylcholine of breast tumour tissue was less evident in the case of the breast tumour phosphatidylinositol in which differences other than those described were seen.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491163

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  4 in total

1.  Chemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects.

Authors:  R Mirnezami; K Spagou; P A Vorkas; M R Lewis; J Kinross; E Want; H Shion; R D Goldin; A Darzi; Z Takats; E Holmes; O Cloarec; J K Nicholson
Journal:  Mol Oncol       Date:  2013-09-14       Impact factor: 6.603

2.  Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai, China.

Authors:  Jackilen Shannon; Irena B King; Johanna W Lampe; Dao Li Gao; Roberta M Ray; Ming-Gang Lin; Helge Stalsberg; David B Thomas
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

Review 3.  Arachidonic acid and cancer risk: a systematic review of observational studies.

Authors:  Mai Sakai; Saki Kakutani; Chika Horikawa; Hisanori Tokuda; Hiroshi Kawashima; Hiroshi Shibata; Hitomi Okubo; Satoshi Sasaki
Journal:  BMC Cancer       Date:  2012-12-19       Impact factor: 4.430

4.  Increased expression of phosphatidylcholine (16:0/18:1) and (16:0/18:2) in thyroid papillary cancer.

Authors:  Seiji Ishikawa; Ichiro Tateya; Takahiro Hayasaka; Noritaka Masaki; Yoshinori Takizawa; Satoshi Ohno; Tsuyoshi Kojima; Yoshiharu Kitani; Morimasa Kitamura; Shigeru Hirano; Mitsutoshi Setou; Juichi Ito
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.